Apart from verifying previously reported associations with a higher risk of insulin-deficient diabetes mellitus, we also expand our understanding of the clinical consequences of genetic PAM deficiency in sarcopenia, a growing medical problem and a major cause of disability, hospitalization, and healthcare costs (26, 35). Here, INS is linked to sarcopenia.